pteridines has been researched along with Leishmaniasis in 2 studies
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nare, B | 1 |
| Luba, J | 1 |
| Hardy, LW | 1 |
| Beverley, S | 1 |
| Cunningham, ML | 1 |
| Beverley, SM | 1 |
1 review available for pteridines and Leishmaniasis
| Article | Year |
|---|---|
New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Topics: Animals; Drug Resistance; Folic Acid Antagonists; Leishmania; Leishmaniasis; Methotrexate; Oxidoredu | 1997 |
1 other study available for pteridines and Leishmaniasis
| Article | Year |
|---|---|
Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
Topics: Animals; Biopterins; Carrier Proteins; Chromatography, High Pressure Liquid; Folic Acid; Folic Acid | 2001 |